The central anticholinergic syndrome: management with physostigmine.
D000328:Adult; D006801:Humans; D008297:Male; D010276:Parasympatholytics / Q000009:adverse effects*; D010830:Physostigmine / Q000627:therapeutic use*; D011605:Psychoses, Substance-Induced / Q000188:drug therapy* / Q000209:etiology
D010276:Parasympatholytics; D010830:Physostigmine